Insiders bought 225K on the open market and sold nothing.
Get an email when XAIR's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13 | Yi-Chien Lin Large holder | Bought | 2,607 | $2.21 | 6K | 1.8% | Form 4 |
| Sep 29 – Oct 1 | Yi-Chien Lin Large holder | Bought 3 parts | 20,393 | $2.77 average | 57K | 16% | Form 4 |
| Jul 29 | Robert Scott Goodman Chief Executive Officer | Bought | 34,722 | $5.76 | 200K | 34722% | Form 4 |
| Jul 29 | Daniel J Moorhead Chief Financial Officer | Bought | 4,340 | $5.76 | 25K | New | Form 4 |
| Jul 21, 2025 | Steven A. Lisi CEO and Chairman of the Board | Bought | 6,000 | $3.25 | 20K | 0.2% | Form 4 |
| Mar 14, 2025 | Robert Carey Director | Bought 2 parts | 1,000,000 | $0.25 average | 250K | 22% | Form 4 |
| Feb 19, 2025 | Michael A. Gaul Chief Operating Officer | Bought | 6,000 | $0.38 | 2K | 6.8% | Form 4 |
- Oct 13Yi-Chien LinLarge holder · bought 2,607 at $2.216K1.8% of stake
- Sep 29 – Oct 1Yi-Chien LinLarge holder · bought 20,393 at avg $2.7757K16% of stake
- Jul 29Robert Scott GoodmanChief Executive Officer · bought 34,722 at $5.76200K34722% of stake
- Jul 29Daniel J MoorheadChief Financial Officer · bought 4,340 at $5.7625KNew position
- Jul 21, 2025Steven A. LisiCEO and Chairman of the Board · bought 6,000 at $3.2520K0.2% of stake
- Mar 14, 2025Robert CareyDirector · bought 1,000,000 at avg $0.25250K22% of stake
- Feb 19, 2025Michael A. GaulChief Operating Officer · bought 6,000 at $0.382K6.8% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Surgical & Medical Instruments & Apparatus · Pick stocks to compare with XAIR
Spot a number that looks wrong? Check it in XAIR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing XAIR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.